21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
58.19.Z - Other publishing activities, excluding software publishing
58.29.Z - Publishing of other software
62.01.Z - Activities related to programming, IT consulting, and related activities
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
70.10.Z - Head office activities
72.11.Z - Scientific research and development activities
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Assets | 0,3 | 4,6 | 1632,1 |
Profit (loss) on sale | -7,6 | -3,4 | 55,8 |
Gross profit (loss) | -7,6 | -3,4 | 55,8 |
Net profit (loss) | -7,6 | -3,4 | 55,8 |
Cash | 0,3 | 2,6 | 882 |
Liabilities and provisions for liabilities | 2,9 | 10,6 | 264,9 |
Net income from sale | 0 | 0 | 0 |
Short time liabilities | 2,9 | 10,6 | 264,9 |
Equity capital | -2,6 | -6 | -127,8 |
Working assets | 0,3 | 2,6 | 882 |
% | % | p.p. | |
Profitability of capital | 289 | 56,1 | -232,9 |
Equity capital to total assets | -997,3 | -131,2 | 866,1 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.09113144874572754 | 0.2452499270439148 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane